For: | Minic Janicijevic S, Jovanovic IP, Gajovic NM, Jurisevic MM, Debnath M, Arsenijevic NN, Borovcanin MM. Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition. World J Psychiatry 2022; 12(9): 1183-1193 [PMID: 36186503 DOI: 10.5498/wjp.v12.i9.1183] |
---|---|
URL: | https://www.wjgnet.com/2220-3192/full/v12/i9/1183.htm |
Number | Citing Articles |
1 |
Milica M. Borovcanin. PsychoNeuroImmunology. Integrated Science 2024; 30: 565 doi: 10.1007/978-3-031-73061-0_17
|
2 |
Abeer Salama, Alaa Hamed Salama, Marwa Hasanein Asfour. Tannic acid coated nanosuspension for oral delivery of chrysin intended for anti-schizophrenic effect in mice. International Journal of Pharmaceutics 2024; 656: 124085 doi: 10.1016/j.ijpharm.2024.124085
|
3 |
Milica M. Borovcanin, Bojan Stojanovic, Milica Dimitrijevic Stojanovic, Bojana S. Stojanovic, Aleksandar Lazovic, Marina Mitrovic. . Interdisciplinary Cancer Research 2024; doi: 10.1007/16833_2024_394
|
4 |
Jose Juan Tascon-Cervera, Maria Lourdes Fernandez-Lopez, Armando Luis Morera-Fumero. Relationships between schizophrenia and the alarmins interleukin-33 (IL-33), soluble receptor of interleukin-33 (sST2) and the ratio IL-33/sST2. A systematic review. Journal of Psychiatric Research 2025; 186: 16 doi: 10.1016/j.jpsychires.2025.03.044
|